Payment overview · 2025
General Payments
$68.30
3 reported records · 2 companies
Healthcare provider profile · identity verified
Warren Everett, MD
Allopathic & Osteopathic Physicians|Family Medicine · HUNTSVILLE, AL · NPI 1487600318
Verified facts
What the public records show
CMS Open Payments records show Warren Everett, MD received $68.30 in general payments during 2025 across 3 reported records.
Exact Sciences Corporation accounted for 67.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $46.13 | 67.5% | 2 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $22.17 | 32.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.30 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $24.90 | 1 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $22.17 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $21.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 623 | 259 |
| Atorvastatin Calcium | Atorvastatin Calcium | 446 | 190 |
| Gabapentin | Gabapentin | 349 | 96 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 305 | 111 |
| Metoprolol Succinate | Metoprolol Succinate | 249 | 112 |
| Fluticasone Propionate | Fluticasone Propionate | 222 | 92 |
| Omeprazole | Omeprazole | 181 | 78 |
| Lisinopril | Lisinopril | 168 | 67 |
| Amitriptyline Hcl | Amitriptyline Hcl | 159 | 59 |
| Tramadol Hcl | Tramadol Hcl | 158 | 30 |
| Losartan Potassium | Losartan Potassium | 151 | 64 |
| Metformin Hcl | Metformin Hcl | 145 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 139 | 55 |
| Meloxicam | Meloxicam | 131 | 65 |
| Pantoprazole Sodium | Pantoprazole Sodium | 130 | 64 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 127 | 55 |
| Clonazepam | Clonazepam | 112 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 112 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 112 | 44 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 109 | 41 |
| Methocarbamol | Methocarbamol | 108 | 52 |
| Hydralazine Hcl | Hydralazine Hcl | 103 | 43 |
| Montelukast Sodium | Montelukast Sodium | 91 | 33 |
| Furosemide | Furosemide | 81 | 43 |
| Carvedilol | Carvedilol | 80 | 44 |
| Glipizide Er | Glipizide | 79 | 28 |
| Spironolactone | Spironolactone | 79 | 38 |
| Clonidine Hcl | Clonidine Hcl | 76 | 34 |
| Doxazosin Mesylate | Doxazosin Mesylate | 74 | 34 |
| Trazodone Hcl | Trazodone Hcl | 73 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 71 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 68 | 32 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 65 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 61 | 32 |
| Ibuprofen | Ibuprofen | 60 | 31 |
| Symbicort | Budesonide/Formoterol Fumarate | 60 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 57 | 25 |
| Jardiance | Empagliflozin | 57 | 18 |
| Pregabalin | Pregabalin | 56 | 14 |
| Buspirone Hcl | Buspirone Hcl | 55 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 55 | 23 |
| Finasteride | Finasteride | 54 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 54 | 22 |
| Eliquis | Apixaban | 53 | 27 |
| Simvastatin | Simvastatin | 51 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 50 | 19 |
| Propranolol Hcl | Propranolol Hcl | 49 | 26 |
| Bupropion Xl | Bupropion Hcl | 48 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 22 |
| Diazepam | Diazepam | 47 | suppressed |
| Famotidine | Famotidine | 47 | 22 |
| Naproxen | Naproxen | 47 | 28 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 46 | 11 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 44 | 23 |
| Mounjaro | Tirzepatide | 44 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 44 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 43 | 15 |
| Allopurinol | Allopurinol | 40 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 18 |
| Metformin Hcl Er | Metformin Hcl | 38 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | 17 |
| Donepezil Hcl | Donepezil Hcl | 36 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 35 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 34 | 13 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 34 | 11 |
| Ozempic | Semaglutide | 34 | 11 |
| Ammonium Lactate | Ammonium Lactate | 33 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | 12 |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 32 | 13 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 32 | 14 |
| Farxiga | Dapagliflozin Propanediol | 31 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 31 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | 14 |
| Celecoxib | Celecoxib | 29 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | 16 |
| Levetiracetam | Levetiracetam | 28 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 28 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Lidocaine | Lidocaine | 27 | suppressed |
| Potassium Chloride | Potassium Chloride | 27 | 22 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | 15 |
| Mupirocin | Mupirocin | 26 | 16 |
| Alendronate Sodium | Alendronate Sodium | 25 | 12 |
| Carbamazepine | Carbamazepine | 25 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 23 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 22 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Phenobarbital | Phenobarbital | 20 | suppressed |
| Fluconazole | Fluconazole | 19 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 11 |
| Risperidone | Risperidone | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 13 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Cephalexin | Cephalexin | 12 | 11 |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.30 · 3 records | Exact Sciences Corporation | Cologuard Collection Kit, Flucelvax, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error